FDA Investigated Recalled Glutathione Injections

The FDA probed adverse reactions linked to compounded glutathione injections contaminated with bacterial endotoxins.

Updated on Sept. 26, 2026 in Alternative Medicine

Isometric editorial illustration of a single medical vial on a metal surface, representing an FDA investigation into drug quality. — The FDA is investigating recalled glutathione injectable products from three compounding pharmacies after discovering elevated levels of bacterial endotoxins. AI Illustration. Upload story photo >

Live Poll

Do you trust that health supplements marketed for cosmetic purposes are safe to use?

In August 2026, the FDA launched an investigation into compounded intravenous glutathione products following reports of adverse reactions in at least 30 patients. The agency identified elevated bacterial endotoxin levels in several recalled products.

Why it matters

The investigation was prompted by concerns that pharmacies used dietary supplement grade ingredients to create injectables, introducing harmful endotoxins into the bloodstream. These contaminants can cause life-threatening symptoms, including shock and inflammation.

The FDA linked adverse patient reactions to injectable glutathione products found to contain elevated bacterial endotoxin levels. At least 30 patients have reported symptoms after receiving the compounded treatments.

The players

Food and Drug Administration

The FDA is a federal agency responsible for protecting public health by ensuring the safety and efficacy of medical products and food.

Centric Compounding

This facility is a compounding pharmacy that issued a recall for multiple lots of glutathione, Myers' Cocktail, and Tri-Immune Boost products.

Victory Medical Center Pharmacy

This pharmacy was identified as one of the entities that recalled certain lots of compounded glutathione due to safety concerns.

Optimal Balance Pharmacy

This pharmacy recalled a lot of compounded glutathione that had been distributed across multiple US states.

The details

Recalls were initiated by Victory Medical Center Pharmacy, Optimal Balance Pharmacy, and Centric Compounding, which pulled six lots of various injectable products. The FDA highlighted that using dietary supplement grade ingredients for injectables is not appropriate for medical use.

The FDA announced its investigation into adverse glutathione events in August 2026.
A report detailing the safety alarms surrounding these products was published in September 2026.

Health Landscape

This incident underscores the distinct safety risks associated with compounded medications, which do not undergo the same rigorous premarket approval process as FDA-approved medicines. The reliance on dietary supplement grade ingredients for injections highlights a significant gap in manufacturing oversight.

Patients who have received compounded glutathione injections should consult their healthcare provider immediately if they experience symptoms like fever or inflammation. These recalls serve as a reminder to verify that any injectable treatment is sourced from a facility following strict sterile compounding standards.

The takeaway

Consumers should exercise extreme caution when considering injectable treatments that are not formally approved by the FDA. Verifying the source and grade of medication ingredients is a vital step in preventing exposure to bacterial contamination.